0001104659-21-087825.txt : 20210630
0001104659-21-087825.hdr.sgml : 20210630
20210630212657
ACCESSION NUMBER: 0001104659-21-087825
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210630
FILED AS OF DATE: 20210630
DATE AS OF CHANGE: 20210630
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: DEMERS WILLIAM L.
CENTRAL INDEX KEY: 0001868214
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39373
FILM NUMBER: 211063701
MAIL ADDRESS:
STREET 1: 4850 WEST 78TH STREET
CITY: INDIANAPOLIS
STATE: IN
ZIP: 46268
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: POINT Biopharma Global Inc.
CENTRAL INDEX KEY: 0001811764
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 850800493
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4850 WEST 78TH STREET
CITY: INDIANAPOLIS
STATE: IN
ZIP: 46268
BUSINESS PHONE: (647) 401-2182
MAIL ADDRESS:
STREET 1: 4850 WEST 78TH STREET
CITY: INDIANAPOLIS
STATE: IN
ZIP: 46268
FORMER COMPANY:
FORMER CONFORMED NAME: Therapeutics Acquisition Corp.
DATE OF NAME CHANGE: 20200511
4
1
tm2121126-12_4seq1.xml
OWNERSHIP DOCUMENT
X0306
4
2021-06-30
0
0001811764
POINT Biopharma Global Inc.
PNT
0001868214
DEMERS WILLIAM L.
4850 WEST 78TH STREET
INDIANAPOLIS
IN
46268
0
1
0
0
Chief Financial Officer
Stock Option (Right to Buy)
6.97
2021-06-30
4
A
0
179362
0.00
A
2026-08-17
Common Stock
179362
179362
D
On June 30, 2021, POINT BIOPHARMA GLOBAL INC. (f/k/a Therapeutics Acquisition Corp., the "Issuer") consummated a business combination (the "Business Combination") pursuant to which RACA, Bodhi Merger Sub, Inc., a wholly-owned subsidiary of the Issuer merged with and into POINT Biopharma Inc., ("Old POINT"). At the effective time of the Business Combination, each option to acquire shares of Old POINT was exchanged for an option to acquire shares of Common Stock of the Issuer based on an implied Old POINT vested equity value of $585,000,000. As a result, the Reporting Person received the reported options to acquire the Issuer's Common Stock in consideration for the options to acquire equity securities of Old POINT held by the Reporting Person prior to the Business Combination.
The option vests 25% on August 17, 2021 with the remaining 75% vesting in three equal annual installments thereafter.
William L. Demers
2021-06-30